{"data":[{"accessionNo":"0002012383-26-003732","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UROGEN PHARMA LTD","ticker":"URGN","cusip":"M96088105","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3058648,"percentOfClass":6.3,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0000947263-26-000072","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-06-30","reportingPerson":"The Toronto-Dominion Bank","reportingCik":null,"personType":"FI","sharesOwned":3269957,"percentOfClass":6.7,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0000947263-26-000072","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-06-30","reportingPerson":"TD SECURITIES INC.","reportingCik":null,"personType":"FI","sharesOwned":101306,"percentOfClass":0.2,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0000947263-26-000047","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-03-31","reportingPerson":"The Toronto-Dominion Bank","reportingCik":null,"personType":"FI","sharesOwned":2616714,"percentOfClass":5.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-26-062615","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-03-31","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":1703949,"percentOfClass":3.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-26-062615","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-03-31","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":1703949,"percentOfClass":3.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-26-062615","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-03-31","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1703949,"percentOfClass":3.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-26-062615","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-03-31","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1501473,"percentOfClass":3.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0000947263-26-000047","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":"M96088105","securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2026-03-31","reportingPerson":"TD SECURITIES INC.","reportingCik":null,"personType":"FI","sharesOwned":1306,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0002012383-26-001661","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001668243","issuerName":"UROGEN PHARMA LTD","ticker":"URGN","cusip":"M96088105","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2519771,"percentOfClass":5.2,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0000947263-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-12-31","reportingPerson":"The Toronto-Dominion Bank","reportingCik":null,"personType":"FI","sharesOwned":2302334,"percentOfClass":4.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-25-112620","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-09-30","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4216084,"percentOfClass":9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-25-112620","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-09-30","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":4216084,"percentOfClass":9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-25-112620","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-09-30","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":4216084,"percentOfClass":9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001104659-25-112620","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-09-30","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":3722066,"percentOfClass":8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0000947263-25-000010","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-09-30","reportingPerson":"The Toronto-Dominion Bank","reportingCik":null,"personType":"FI","sharesOwned":3190510,"percentOfClass":6.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"},{"accessionNo":"0001771015-25-000010","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001668243","issuerName":"UroGen Pharma Ltd.","ticker":"URGN","cusip":null,"securityClass":"Ordinary Shares, par value NIS 0.01 per share","eventDate":"2025-09-30","reportingPerson":"Cowen Financial Products LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/urgn"}],"updatedAt":"2026-11-03T18:40:25.553Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/urgn","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}